Literature DB >> 16002848

Endoscopic techniques to diagnose and manage biliary tumors.

William R Brugge1.   

Abstract

Malignancies of the bile duct are often suspected in patients with abnormal serum hepatic enzyme levels and obstruction of the biliary system. Although cross-sectional imaging can provide evidence for biliary obstruction and a malignancy arising from the bile duct, a definitive diagnosis is often obtained through the use of endoscopic procedures. Endoscopic retrograde cholangiopancreatography (ERCP), the most commonly performed procedure for cholangiocarcinoma, can provide a tissue diagnosis through brush cytology of the bile duct. Relief from biliary obstruction can be provided with temporary plastic stenting or permanent metal stenting. Photodynamic therapy guided by ERCP may provide improved palliation from biliary obstruction in the future. Endoscopic ultrasonography complements the role of ERCP and may provide a tissue diagnosis through fine-needle aspiration and staging through ultrasound imaging. High-resolution ultrasound images can provide detailed information regarding the relationship between a mass and the bile duct wall. Despite these advances in endoscopic techniques and imaging of the bile duct, a tissue diagnosis often remains elusive in many patients. In the future, molecular markers will be employed to improve the sensitivity for the detection of malignancy in bile duct samples obtained through brushing, aspiration, and biopsy.

Entities:  

Mesh:

Year:  2005        PMID: 16002848     DOI: 10.1200/JCO.2005.19.729

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  10 in total

Review 1.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 2.  Cholangiocarcinoma--controversies and challenges.

Authors:  Tushar Patel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

Review 3.  Cholangiocarcinoma: has there been any progress?

Authors:  Judith Meza-Junco; Aldo J Montano-Loza; Mang Ma; Winnie Wong; Michael B Sawyer; Vincent G Bain
Journal:  Can J Gastroenterol       Date:  2010-01       Impact factor: 3.522

4.  Pancreaticopleural fistula: An insidious cause of pleural effusion -case report.

Authors:  Fábio Murteira; Tiago Costa; Sara Barbosa Pinto; Elsa Francisco; Ana Catarina Gomes
Journal:  J Cardiovasc Thorac Res       Date:  2021-09-06

5.  Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma.

Authors:  Andreas Weber; Claus von Weyhern; Falko Fend; Jochen Schneider; Bruno Neu; Alexander Meining; Hans Weidenbach; Roland M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 6.  Scanning single fiber endoscopy: a new platform technology for integrated laser imaging, diagnosis, and future therapies.

Authors:  Eric J Seibel; Christopher M Brown; Jason A Dominitz; Michael B Kimmey
Journal:  Gastrointest Endosc Clin N Am       Date:  2008-07

7.  Trimming of a Broken Migrated Biliary Metal Stent with the Nd:YAG Laser.

Authors:  I Zuber-Jerger; F Kullmann
Journal:  Case Rep Gastroenterol       Date:  2009-03-28

Review 8.  Diagnostic approaches for cholangiocarcinoma.

Authors:  Andreas Weber; Roland-M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

Review 9.  Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review.

Authors:  Geng Zhimin; Hidayatullah Noor; Zheng Jian-Bo; Wang Lin; Rajiv Kumar Jha
Journal:  Med Sci Monit       Date:  2013-08-07

10.  Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing.

Authors:  Kwai Han Yoo; Nayoung K D Kim; Woo Il Kwon; Chung Lee; Sun Young Kim; Jiryeon Jang; Jungmi Ahn; Mihyun Kang; Hyojin Jang; Seung Tae Kim; Soomin Ahn; Kee-Taek Jang; Young Suk Park; Woong-Yang Park; Jeeyun Lee; Jin Seok Heo; Joon Oh Park
Journal:  Transl Oncol       Date:  2016-04-22       Impact factor: 4.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.